Quick Summary
Molnatris 200mg Capsule
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹1262
MRP: ₹1846.88
(You Save ₹584.88)
40 CAPSULE(s) IN A BOTTLE
32% OFF
₹1262
MRP: ₹1,846.88
Inclusive of all taxes
32% Off
Product Discontinued
Substitutes
Molena 200mg Capsule
EMCURE PHARMACE...
₹ 32.73/capsule
4% costlier
Molnunat 200mg Capsule
NATCO PHARMA LT...
₹ 37.50/capsule
19% costlier
Movfor 200mg Capsule
HETERO HEALTHCA...
₹ 42.63/capsule
36% costlier
Introduction to Molnatris 200mg Capsule
Molnatris 200mg Tablet is an antiviral medication containing the active constituent Molnupiravir. It treats mild to moderate COVID-19 (Coronavirus disease) in people at risk for developing severe illness. COVID-19 is a highly infectious disease caused by the SARS-CoV-2 virus. The most common symptoms are dry cough, fever, and fatigue. Other symptoms such as nasal congestion, loss of taste or smell, diarrhea, or sore throat can also occur.
People aged sixty years and over with diabetes, high blood pressure, cancer, heart and lung problems, or obesity are at greater risk of developing serious illnesses from COVID-19. Molnatris 200mg Tablet is not recommended for adolescents and children under 18. This drug must be taken within five days of the onset of symptoms to be most effective. Molnatris 200mg Tablet could also provide an alternative treatment option for COVID-19 patients who cannot receive or do not respond well to existing treatments, such as monoclonal antibodies or remdesivir.
Uses of Molnatris 200mg Capsule
Molnatris 200mg Tablet are used in the treatment of
- Treatment of COVID-19
Therapeutic Effects of Molnatris 200mg Capsule
The therapeutic effect of Molnatris 200mg Tablet is to reduce the severity of COVID-19 symptoms and prevent the virus from replicating and spreading within the body. This is accomplished by introducing errors into the genetic material of the virus, which can ultimately render it unable to reproduce and cause further harm.
Interaction of Molnatris 200mg Capsule with other drugs
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Molnatris 200mg Tablet, reducing effectiveness by causing undesirable side effects.
More Information about Molnatris 200mg Capsule
- Store in a refrigerator between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep it in its original packaging until it is ready to be used.
- Keep out of the reach of children and pets.
How to consume Molnatris 200mg Capsule
Take Molnatris 200mg Tablet in the dose and duration prescribed by your doctor. Swallow the medication whole with plenty of water. Do not chew or crush the capsules. This capsule can be taken with or without food. Do not skip or miss doses.
Safety Advice for Molnatris 200mg Capsule
Breast Feeding
It is unknown if Molnatris 200mg Tablet is excreted in human breast milk, so breastfeeding women should consult a healthcare provider.
Alcohol
It is generally recommended to avoid consuming alcohol while taking Molnatris 200mg Tablet. Alcohol can worsen liver-related side effects.
Liver
Molnatris 200mg Tablet is metabolized in the liver, and its use may be associated with potential liver toxicity. Patients with preexisting liver disease or impairment may be at an increased risk for adverse effects when taking these medications.
Lungs
Molnatris 200mg Tablet can potentially cause side effects, which may affect the lungs or other parts of the body. So patients with pre-existing lung disease should consult a healthcare provider.
Driving
Patients should always monitor their response to the Molnatris 200mg Tablet medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
Pregnancy
Molnatris 200mg Tablet is not recommended for pregnant women as it can cause fetal harm.
Side Effects of Molnatris 200mg Capsule
Molnatris 200mg Tablets cause some side effects like all medications, although not everyone will experience them.
Serious:
- Severe allergic reactions (such as difficulty breathing, hives, or swelling of the face, lips, tongue, or throat)
- Severe diarrhea (with blood or mucus)
- Stomach pain or cramping
- Liver toxicity
- Yellowing of the skin or eyes (jaundice)
- Dark urine or pale stools
Common:
- Nausea
- Diarrhea
- Headache
- Fatigue
- Dizziness
- Insomnia
Word of Advice
If you have been prescribed Molnatris 200mg Tablet, it is important to carefully read and understand the warnings and precautions associated with the medication. It increases the risk of infection, so patients should avoid close contact with infected persons. Pregnant and breastfeeding women should consult with a healthcare provider before taking it. Use effective birth control measures while taking this medicine and for at least four days after the last dose. Do not stop taking it without consulting your physician, as it will increase the chance of becoming severely ill from COVID-19. Patients should avoid contact with infected patients. Always maintain a healthy and balanced diet to support your overall health and well-being.
FAQs about Molnatris 200mg Capsule
Q1.
Can Molnatris 200mg Tablet be used to prevent COVID-19?
Molnatris 200mg Tablet is currently being studied as a post-exposure prophylaxis (PEP) to prevent COVID-19 infection in people exposed to the virus. However, it is not currently approved for this use.
Q2.
Can Molnatris 200mg Tablet be used to treat other viral infections?
Molnatris 200mg Tablet is a broad-spectrum antiviral medication effective against various RNA viruses in laboratory studies. It is currently being studied for other viral infections, such as influenza, but it is not approved for any indication other than COVID-19.
Q3.
Can Molnatris 200mg Tablet be taken with food?
Yes, Molnatris 200mg Tablet can be taken with or without food. However, taking the medication with food may help reduce the risk of gastrointestinal side effects.
Q4.
Can Molnatris 200mg Tablet be used in pediatric patients?
Molnatris 200mg Tablet has not been studied in pediatric patients under 18, and the drug is not currently approved for use in this population. Studies are ongoing to evaluate the safety and efficacy in pediatric patients.
Q5.
Can Molnatris 200mg Tablet be used to treat severe COVID-19?
Molnatris 200mg Tablet is currently being studied for use in mild to moderate COVID-19 cases and is not recommended for use in severe cases of the disease. It is important to consult with a healthcare provider to determine the appropriate treatment for COVID-19 based on the patient's health status and symptoms.
Q6.
Can Molnatris 200mg Tablet be used as a substitute for COVID-19 vaccines?
No, Molnatris 200mg Tablet is not a substitute for COVID-19 vaccines. Vaccines are the most effective way to prevent COVID-19 infection and its complications, while Molnatris 200mg Tablet is a treatment for people who have already been infected.
Q7.
Can I use Molnatris 200mg Tablet for impaired kidney patients?
The safety and efficacy of Molnatris 200mg Tablet in patients with impaired kidney function have yet to be specifically studied. However, according to the prescribing information, it is primarily eliminated through the liver and does not undergo significant renal excretion. Therefore, no dose adjustment is recommended for patients with mild to moderate kidney impairment.
Fact Box of Molnatris 200mg Capsule
Molecule name: Molnupiravir | Therapeutic class: Antiviral agents |
Pharmacological class: Nucleoside Analogues | Indications: Treatment of COVID-19 |
References
- Merck Sharp & Dohme (UK) Limited, Electronic medicines compendium (emc), [ Revised on Nov 2021] [ Accessed on 9th May 2023], https://www.medicines.org.uk/emc/files/pil.13044.pdf
- Florian Kabinger et al; Mechanism of Molnupiravir-induced SARS-CoV-2 mutagenesis; Nature Structural & Molecular Biology; [Published on 11/08/2021]; [Accessed on 9 May 2023]; https://www.nature.com/articles/s41594-021-00651-0
- William Fischer et al; Molnupiravir, an Oral Antiviral Treatment for COVID-19; medRxiv; [Published on 17/06/2021]; [Accessed on 9th May 2023], https://pubmed.ncbi.nlm.nih.gov/34159342/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy